Tenascin: A potential role in human arteriovenous PTFE graft failure

被引:16
作者
Chen, CY
Ku, DN
Kikeri, D
Lumsden, AB
机构
[1] VET AFFAIRS MED CTR,DEPT SURG,DECATUR,GA 30033
[2] EMORY UNIV,SCH MED,ATLANTA,GA 30322
关键词
D O I
10.1006/jsre.1996.0067
中图分类号
R61 [外科手术学];
学科分类号
摘要
To investigate the involvement of tenascin (TN) in human neointimal hyperplastic lesion formation, we studied 12 human arteriovenous (AV) polytetrafluoroethylene (PTFE) loop grafts removed at the time of graft revision. Immunoperoxidase technique was used to determine TN and proliferating cell nuclear antigen (PCNA) as an index of cell proliferation. The venous anastomotic neointimal hyperplastic lesion was analyzed as three layers, each one-third of the thickness. TN was distributed in the neointima as follows: (1) in the luminal layer, all lesions were intensely stained; (2) in the middle layer, 9 of 12 (75%) lesions had moderate reactivity; (3) in the deep layer near the PTFE grafts, 3 of 12 (25%) lesions were strongly stained and 5 of 12 (42%) had moderate reactivity; and (4) 90 +/- 6% of microvessels within the neointima showed intense periendothelial staining. PCNA indices were as follows: luminal layer, 29 +/- 11%; middle layer, 9 +/- 5%; deep layer near the graft, 9 +/- 7%; and microvessel-containing intimal fields, 67 +/- 4%. The cell proliferation rate was significantly higher in the luminal layer than in the middle or deep layers of neointima (P < 0.05). The PCNA index in microvessel-containing intimal fields was three to eight times that of avascular fields (P < 0.001). These data demonstrate that TN is distributed in a pattern similar to that of cell proliferation in human neointimal hyperplastic lesions. The results suggest that TN expression may have a potential role in neovascularization and neointimal growth inhuman AV PTFE graft failure. (C) 1996 Academic Press, Inc.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 35 条
[1]  
CHEN C, 1995, 5 ANN WINT M PER VAS
[2]  
Chen Changyi, 1994, Surgical Forum, V45, P382
[3]  
CHEN CY, 1994, J AM SOC NEPHROL, V5, P411
[4]  
Choi Eric T., 1994, Surgical Forum, V45, P353
[5]  
CONNOLLY JE, 1984, ARCH SURG-CHICAGO, V119, P1325
[6]  
DOBRIN PB, 1989, SURGERY, V105, P393
[7]   TENASCIN - A MODULATOR OF CELL-GROWTH [J].
END, P ;
PANAYOTOU, G ;
ENTWISTLE, A ;
WATERFIELD, MD ;
CHIQUET, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 209 (03) :1041-1051
[8]   A 6-ARMED OLIGOMER ISOLATED FROM CELL-SURFACE FIBRONECTIN PREPARATIONS [J].
ERICKSON, HP ;
INGLESIAS, JL .
NATURE, 1984, 311 (5983) :267-269
[9]   TENASCIN DISTRIBUTION IN THE NORMAL HUMAN BREAST IS ALTERED DURING THE MENSTRUAL-CYCLE AND IN CARCINOMA [J].
FERGUSON, JE ;
SCHOR, AM ;
HOWELL, A ;
FERGUSON, MWJ .
DIFFERENTIATION, 1990, 42 (03) :199-207
[10]   MECHANISMS OF DISEASE - THE PATHOGENESIS OF CORONARY-ARTERY DISEASE AND THE ACUTE CORONARY SYNDROMES .1. [J].
FUSTER, V ;
BADIMON, L ;
BADIMON, JJ ;
CHESEBRO, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (04) :242-250